VCIM
MGNX icon

Velan Capital Investment Management’s MacroGenics MGNX Stock Holding History

Velan Capital Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
60,000
+30,000
+100% +$113K 0.17% 32
2026
Q1 		$86.7K Buy
+30,000
New +$64K 0.05% 46

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Velan Capital Investment Management's MGNX Position: Q2 2026 in Review

Velan Capital Investment Management increased its MacroGenics (MGNX) stake by 100% in Q2 2026, buying an estimated $113K and bringing the position to 60,000 shares worth $277K. The position accounts for 0.17% of the portfolio, ranked #32.

Velan Capital Investment Management first reported a position in MGNX in Q1 2026 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Velan Capital Investment Management held 60,000 shares of MacroGenics worth $277K as of Q2 2026.
  • Velan Capital Investment Management bought 30,000 MacroGenics shares in Q2 2026, an estimated $113K.
  • MacroGenics made up 0.17% of Velan Capital Investment Management's portfolio in Q2 2026, its #32 holding.
  • Velan Capital Investment Management first reported a position in MacroGenics in Q1 2026 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Velan Capital Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.